Amutha Boominathan
Group Lead for the MitoSENS program at SENS Research Foundation
Dr. Boominathan obtained her Ph.D in Biochemistry from the National Chemical Laboratory, India and subsequently had her postdoctoral training at the University of Pennsylvania and Rutgers University.
As an American Heart Association Postdoctoral Fellow, she studied protein import into mitochondria, Fe-S cluster biosynthesis and mechanisms of fusion and fission in mitochondria.
With more than 18 years of experience in mitochondrial biogenesis, she leads a highly motivated team of researchers at SRF in furthering our understanding and developing therapies for myopathies from mitochondrial DNA (mtDNA) mutations.
Visit website: https://www.lifespan.io/dr-amutha-boominathan/
See also: SENS Research Foundation - Non-profit organization focused on transforming the way the world researches and treats age-related diseases
Details last updated 13-Apr-2020
Amutha Boominathan is also referenced in the following:
Ending Aging Forum 2022
02-Sep-2022 to 03-Sep-2022
Science and Education virtual conference organized by SENS Research Foundation (FREE)
Ending Aging Forum 2023
21-Sep-2023 to 22-Sep-2023
Virtual conference about new rejuvenation biotechnologies organized by SENS Research Foundation (Mountain View, CA, FREE)
Longevity Investors Conference
27-Sep-2021
Online conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
Amutha Boominathan News
How SENS is tackling mitochondrial DNA damage
Lifespan.io (LEAF) - 17-Jan-2020
Amutha Boominathan presented her work on MitoSENS project at Ending Age-Related Diseases 2019
Read more...